Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dienes

Showing results (661-670 of 715) with videos related to

Pageof 72
Sort By:
Journal of Viral Hepatitis|June 12, 2018
Viral dominance patterns in chronic hepatitis delta determine early response to interferon alpha therapyG L Lutterkort, A Wranke, J Hengst, et al.
The New England Journal of Medicine|January 28, 2011
Peginterferon plus adefovir versus either drug alone for hepatitis deltaHeiner Wedemeyer, Cihan Yurdaydìn, George N Dalekos, et al.
Cell Death & Disease|October 27, 2017
The non-invasive serum biomarker soluble Axl accurately detects advanced liver fibrosis and cirrhosisKatharina Staufer, Mirko Dengler, Heidemarie Huber, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 19, 2019
Chronic Hepatitis E is associated with cholangitisAndrea Beer, Heidemarie Holzmann, Sven Pischke, et al.
Histopathology|May 16, 2002
Comparative evaluation of the prognostic value of MUC1, MUC2, sialyl-Lewis(a) and sialyl-Lewis(x) antigens in colorectal adenocarcinomaS E Baldus, S P Mönig, F-G Hanisch, et al.
Antiviral Therapy|February 2, 2012
Anti-HDV immunoglobulin M testing in hepatitis delta revisited: correlations with disease activity and response to pegylated interferon-α2a treatmentIngmar Mederacke, Cihan Yurdaydin, George N Dalekos, et al.
BMC Public Health|September 20, 2021
Low socioeconomic position is a risk factor for delay to treatment and mortality of testicular cancer patients in Hungary, a prospective studyZsófia Küronya, Georgina Fröhlich, Andrea Ladányi, et al.
Journal of Hepatology|February 14, 2015
Hepatic steatosis in Wilson disease--Role of copper and PNPLA3 mutationsAlbert Friedrich Stättermayer, Stefan Traussnigg, Hans-Peter Dienes, et al.
Journal of Cell Science|March 2, 2006
Radial spoke proteins of Chlamydomonas flagellaPinfen Yang, Dennis R Diener, Chun Yang, et al.
International Journal of Cancer|January 20, 2007
Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancerNiklas Reimers, Hans U Kasper, Soenke J Weissenborn, et al.
Pageof 72

Showing results (661-670 of 715) with videos related to

Sort By:
Pageof 72
Journal of Viral Hepatitis|June 12, 2018
Viral dominance patterns in chronic hepatitis delta determine early response to interferon alpha therapyG L Lutterkort, A Wranke, J Hengst, et al.
The New England Journal of Medicine|January 28, 2011
Peginterferon plus adefovir versus either drug alone for hepatitis deltaHeiner Wedemeyer, Cihan Yurdaydìn, George N Dalekos, et al.
Cell Death & Disease|October 27, 2017
The non-invasive serum biomarker soluble Axl accurately detects advanced liver fibrosis and cirrhosisKatharina Staufer, Mirko Dengler, Heidemarie Huber, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 19, 2019
Chronic Hepatitis E is associated with cholangitisAndrea Beer, Heidemarie Holzmann, Sven Pischke, et al.
Histopathology|May 16, 2002
Comparative evaluation of the prognostic value of MUC1, MUC2, sialyl-Lewis(a) and sialyl-Lewis(x) antigens in colorectal adenocarcinomaS E Baldus, S P Mönig, F-G Hanisch, et al.
Antiviral Therapy|February 2, 2012
Anti-HDV immunoglobulin M testing in hepatitis delta revisited: correlations with disease activity and response to pegylated interferon-α2a treatmentIngmar Mederacke, Cihan Yurdaydin, George N Dalekos, et al.
BMC Public Health|September 20, 2021
Low socioeconomic position is a risk factor for delay to treatment and mortality of testicular cancer patients in Hungary, a prospective studyZsófia Küronya, Georgina Fröhlich, Andrea Ladányi, et al.
Journal of Hepatology|February 14, 2015
Hepatic steatosis in Wilson disease--Role of copper and PNPLA3 mutationsAlbert Friedrich Stättermayer, Stefan Traussnigg, Hans-Peter Dienes, et al.
Journal of Cell Science|March 2, 2006
Radial spoke proteins of Chlamydomonas flagellaPinfen Yang, Dennis R Diener, Chun Yang, et al.
International Journal of Cancer|January 20, 2007
Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancerNiklas Reimers, Hans U Kasper, Soenke J Weissenborn, et al.
Pageof 72